Major new research programme could fast-track health service improvement in low and middle-income countriesMonday 19 October 2020
As I left the UN General Assembly High-Level Meeting on Ending TB in New York two years ago, there was renewed hope that this could be a turning point for accelerating progress against tuberculosis (TB). But COVID-19 has shifted global TB control from acceleration into reverse.
Also contributing to this opinion piece were: Sharifah Sekalala, Associate Professor at the University of Warwick; Judith Bueno de Mesquita, Co-Deputy Director at the Human Rights Centre, University of Essex; Claire Lougarre, Lecturer and Director of the Centre for Health Ethics and Law at the University of Southampton; and Michel Coleman, Professor of Epidemiology and Vital Statistics at the London School of Hygiene & Tropical Medicine.
Antimicrobial resistance threatens one of the most important infrastructures created in the past century: antibiotics. At first glance, it may seem odd to think of antibiotics as infrastructure. Think again. These drugs are everywhere. So engrained has their use become that we now expect – rather than pray for – infectious diseases to be cured. But antibiotics are not only used in the treatment of acute infections.
Manipulation of the chicken gut microbiome, a possible way to reduce Campylobacter and improve poultry performance?
Chickens are a key source of protein for humans. The poultry industry is predicted to produce approximately 130 million tons of chicken meat in 2020. It is critical that we have sustainable practices to maintain an adequate supply of poultry products for the increasing human population without compromising chicken or human health.